跳至主要内容
临床试验/EUCTR2014-000197-19-IT
EUCTR2014-000197-19-IT进行中(未招募)1 期

Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing PercuTaneous Coronary Intervention: DiffErences Between the LoAding Dose of Ticagrelor and PrasugrEl. - DELATE

MBERTO I - POLICLINICO DI ROMA0 个研究点目标入组 90 人开始时间: 2021年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with ACS (acute coronary syndromes) undergoing PCI with
  • stent implantation;
  • Patients = 18 and = 75 years old;
  • Signed informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Patients with stable angina;
  • prior myocardial infarction;
  • prior revascularization (PCI or CABG-coronary artery bypass
  • Prasugrel and/or Ticagrelor contraindications (history of intracranial
  • hemorrhage, active pathological bleeding, severe hepatic impairment);
  • major periprocedural complications;
  • GFR ( glomerular filtration rate) < 30 ml/min or requiring
  • haemodialysis;
  • Non-sinus rhythm;
  • severe COPD (chronic obstructive pulmonary disease);
  • requirement for oral anticoagulant;
  • risk of bleeding or bradycardic events;
  • EF (ejection fraction) < 45%;
  • Cardiogenic shock;
  • Severe left ventricular hypertrophy;
  • severe valvular disease;
  • indication to CABG;
  • diffuse coronary atherosclerosis;

研究者

发起方
MBERTO I - POLICLINICO DI ROMA

相似试验